Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Down 45.5% in February

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) saw a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 3,600 shares, a decrease of 45.5% from the January 31st total of 6,600 shares. Based on an average daily volume of 37,500 shares, the days-to-cover ratio is presently 0.1 days.

Reviva Pharmaceuticals Stock Performance

Shares of RVPHW traded up $0.00 during mid-day trading on Friday, reaching $0.13. The company’s stock had a trading volume of 2,558 shares, compared to its average volume of 26,348. Reviva Pharmaceuticals has a 1-year low of $0.07 and a 1-year high of $0.85. The business has a 50-day simple moving average of $0.18 and a two-hundred day simple moving average of $0.16.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.